A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
Clinical trial NCT05679908 · COMPLETED
Trial details
- NCT number
- NCT05679908
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2023-10-08
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.